Freightos (CRGO) strategy chief discloses options and RSU awards

Rhea-AI Filing Summary

Freightos Ltd filed a Form 3 showing that Chief Strategy Officer Ian Arroyo holds ordinary shares, restricted share units (RSUs), and stock options. The derivative positions include stock options over 49,473 ordinary shares at an exercise price of $1.07 expiring on December 16, 2030, and additional options over 12,314 and 228,674 ordinary shares at an exercise price of $4.17 expiring on July 19, 2031 and February 17, 2032, respectively. Footnotes explain that several ordinary share entries represent RSUs that vest and settle into shares on specified dates between 2026 and 2027, with some vesting entirely on single dates and others vesting quarterly.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Arroyo Ian

(Last) (First) (Middle)

C/O FREIGHTOS LIMITED, PLANTA 10

AVDA. DIAGONAL, 211

(Street)

BARCELONA 08018

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Freightos Ltd [ CRGO ]

3a. Foreign Trading Symbol
[N/A]

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Strategy Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary shares	21,141	D
Ordinary shares(1)	37,500	D
Ordinary shares(2)	37,500	D
Ordinary shares(3)	36,000	D
Ordinary shares(4)	7,000	D
Ordinary shares(5)	21,500	D
Ordinary shares(6)	38,000	D
Ordinary shares(7)	38,000	D
Ordinary shares(8)	54,600	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock options (right to buy)	12/01/2024	12/16/2030	Ordinary shares	49,473	$1.07	D
Stock options (right to buy)	07/01/2025	07/19/2031	Ordinary shares	12,314	$4.17	D
Stock options (right to buy)	01/01/2026	02/17/2032	Ordinary shares	228,674	$4.17	D

Explanation of Responses:

1. The ordinary shares reported in this row consist of shares underlying restricted share units ("RSUs") granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 31, 2027.

2. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on March 13, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on July 15, 2026.

3. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on July 1, 2025 and that vest (and settle for underlying ordinary shares) in accordance with the following schedule: 33.33% of the RSUs vest upon the one-year anniversary of the vesting commencement date, and the remaining RSUs vest equally on a quarterly basis over the following eight quarters (8.3325% per quarter) such that all such RSUs will be vested by the three-year anniversary of the vesting commencement date.

4. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) on an equal, quarterly basis (33.33% per quarter) such that all such RSUs will be vested by July 15, 2026.

5. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) on an equal, quarterly basis (approximately 14.286% per quarter) such that all such RSUs will be vested by July 15, 2027.

6. The ordinary shares reported in this row consist of shares underlying RSUs granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2026.

7. The ordinary shares reported in this row consist of shares underlying RSUs that were granted to the Reporting Person by the Issuer that began vesting on October 15, 2025 and that vest (and settle for underlying ordinary shares) in their entirety on December 30, 2027.

8. The options reported in this row vest and become exercisable for underlying ordinary shares in accordance with the following schedule: 50% of the options vest on the one-year anniversary of the vesting commencement date (March 16, 2027) and the remaining 50% of the options vest on the two-year anniversary of the vesting commencement date (March 16, 2028).

Remarks:

Exhibit List - Exhibit 24.1 - Power of Attorney.

	/s/ Michael Oberlander, attorney-in-fact	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the Freightos (CRGO) Form 3 filing for Ian Arroyo show?

The Form 3 shows Chief Strategy Officer Ian Arroyo’s existing equity stake in Freightos Ltd, including ordinary shares, restricted share units, and stock options over hundreds of thousands of ordinary shares with defined exercise prices and long-dated expirations into 2030–2032.

What stock options does Ian Arroyo hold in Freightos (CRGO)?

Ian Arroyo holds stock options over 49,473 ordinary shares at $1.07 per share expiring December 16, 2030, plus options over 12,314 and 228,674 ordinary shares at $4.17 per share, expiring July 19, 2031 and February 17, 2032, respectively.

How are Ian Arroyo’s RSUs in Freightos (CRGO) structured?

Several ordinary share lines represent RSUs that began vesting in 2025 and vest fully by dates in 2026 or 2027. Some RSUs vest entirely on single dates, while others vest quarterly in equal or specified percentages until fully vested.

Does the Freightos (CRGO) Form 3 show Ian Arroyo buying or selling shares?

The entries are classified as holdings rather than new purchases or sales. The filing mainly lists Arroyo’s existing ordinary shares, RSUs, and stock options, along with their vesting schedules and expiration dates, rather than reporting open-market transactions.

What is the significance of the option expiration dates for Freightos (CRGO)?

Option expiration dates through 2030, 2031, and 2032 indicate long-term equity incentives. These timeframes show how long Ian Arroyo retains the right to exercise options for ordinary shares at the stated exercise prices, subject to vesting.